What Are The Chances Of Third Harmonic Bio Inc (NASDAQ: THRD) Becoming A Clear Buy?

After Hours

There may be slightly higher risks associated with pre-market and after-hours trading than during regular market hours. Due to the fact that issuers often announce critical financial information outside of regular trading hours, extended-hours trading may result in wider spreads for particular securities.

Stocks Info

As a NASDAQ listed company, THRD falls under the Healthcare sector while operating within the Biotechnology industry segment. The current market capitalization of Third Harmonic Bio Inc is $156.35M. A total of 0.51 million shares were traded on the day, compared to an average of 569.04K shares.

In the most recent transaction, Conner Edward R. sold 2,117 shares of THRD for 15.00 per share on Nov 08 ’24. After the transaction, the Chief Medical Officer now owns 0 company shares. In a previous transaction on Oct 29 ’24, BVF PARTNERS L P/IL sold 1,000,000 shares at 14.30 per share. THRD shares that See Explanation of Responses owns now total 176,692.

Among the insiders who sold shares, Conner Edward R. disposed of 2,673 shares on Oct 28 ’24 at a per-share price of $15.00. This resulted in the Chief Medical Officer holding 0 shares of THRD after the transaction. In another insider transaction, EDWARD CONNER bought 4,790 shares at $13.15 per share on Oct 28 ’24.

In spite of price targets being rarely accurate, it tends to exert some kind influence from time to time, and was often accepted by the market as having some value. In terms of 52-week highs and lows, THRD has a high of $16.94 and a low of $3.18.

As of this writing, THRD has an earnings estimate of -$0.33 per share for the current quarter. EPS was calculated based on a consensus of 2.0 estimates, with a high estimate of -$0.32 per share and a lower estimate of -$0.34.

Balance Sheet Annually/Quarterly

The balance sheet of a company shows what assets and liabilities a company has, as well as the amount, equity investors have invested. With the help of this information, a company’s financial ratios can be calculated to give investors an overview of the company’s prospects. THRD’s latest balance sheet shows that the firm has $128.28M in Cash & Short Term Investments as of fiscal 2021. There were $0.00 in debt and $5.69M in liabilities at the time. Its Book Value Per Share was $6.59, while its Total Shareholder’s Equity was -$46.71M.

Analysts Opinion

The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for THRD is Buy with a score of 3.80.

Most Popular

Related Posts